AVT Form 4: Senior VP Jay Youngblood Granted 5,680 RSUs (Most Unvested)
Rhea-AI Filing Summary
Avnet director and Senior Vice President, Chief Digital Officer Jay David Youngblood reported changes in his beneficial ownership on Form 4. The filing shows an acquisition of 5,680 shares in the form of Restricted Stock Units (RSUs) on 08/21/2025 with a reported price of $0, bringing his total reported beneficial ownership to 8,250 shares. The filing notes that 7,762 of those shares are underlying RSUs that have been allocated but have not yet vested. The Form 4 was signed by an attorney-in-fact on 08/25/2025.
This disclosure documents a routine equity compensation-related acquisition rather than an open-market purchase or sale; the transaction codes and explanations identify the shares as earned under long-term incentive plans rather than a cash purchase.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider received RSUs, increasing reported ownership to 8,250 shares; most remain unvested.
The Form 4 documents a non‑market acquisition of 5,680 RSUs credited to Jay David Youngblood on 08/21/2025, with total beneficial ownership of 8,250 shares and 7,762 shares still subject to vesting. Because the reported price is $0 and the explanation cites long‑term incentive plans, this is a compensation event rather than a discretionary purchase or sale. For investors monitoring insider alignment, the grant signals continued use of equity incentives to retain senior management but does not change outstanding share count or signal immediate liquidity events.
TL;DR: Routine equity award disclosed; materiality is low absent vesting schedule or size relative to outstanding shares.
The filing meets Section 16 reporting requirements by disclosing the RSU award and the resulting beneficial ownership. The material facts disclosed are the 5,680 RSUs acquired and the 7,762 RSUs allocated but unvested. Missing from the filing are vesting dates and any conditions attaching to the RSUs, which would be relevant to assess retention incentives and potential future dilution. On its face, the transaction appears to be a standard compensation grant and is likely immaterial to the company's capital structure in isolation.